Abbott Laboratories (ABT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2014 | 06-2014 | 03-2014 | 12-2013 | 09-2013 | |
| Sales | 5,079,000 | 5,057,000 | 4,755,000 | 4,008,000 | 4,825,000 |
| Cost of Goods | 2,319,000 | 2,288,000 | 2,274,000 | 1,961,000 | 2,255,000 |
| Gross Profit | 2,760,000 | 2,769,000 | 2,481,000 | 2,047,000 | 2,570,000 |
| Operating Expenses | 2,032,000 | 2,092,000 | 2,116,000 | 1,629,000 | 2,097,000 |
| Operating Income | 728,000 | 677,000 | 365,000 | 418,000 | 473,000 |
| Interest Expense | 35,000 | 36,000 | 36,000 | 27,000 | 37,000 |
| Other Income | 22,000 | 17,000 | 12,000 | 14,000 | 45,000 |
| Pre-tax Income | 715,000 | 658,000 | 341,000 | 405,000 | 481,000 |
| Income Tax | 277,000 | 233,000 | 117,000 | 81,000 | -163,000 |
| Net Income Continuous | 438,000 | 425,000 | 224,000 | 324,000 | 644,000 |
| Net Income Discontinuous | 100,000 | 41,000 | 151,000 | 266,000 | 322,000 |
| Net Income | $538,000 | $466,000 | $375,000 | $590,000 | $966,000 |
| EPS Basic Total Ops | 0.36 | 0.31 | 0.24 | 0.37 | 0.62 |
| EPS Basic Continuous Ops | 0.29 | 0.28 | 0.14 | 0.21 | 0.41 |
| EPS Basic Discontinuous Ops | 0.07 | 0.03 | 0.10 | 0.16 | 0.21 |
| EPS Diluted Total Ops | 0.36 | 0.30 | 0.24 | 0.37 | 0.61 |
| EPS Diluted Continuous Ops | 0.29 | 0.28 | 0.14 | 0.21 | 0.41 |
| EPS Diluted Discontinuous Ops | 0.07 | 0.02 | 0.10 | 0.16 | 0.20 |
| EBITDA(a) | $1,083,000 | $1,077,000 | $763,000 | $844,000 | $909,000 |